NU553 Unit 3 Substance Use Disorders Advanced Pharmacology and Pharmacotherapeutics Exam 2

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/75

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 12:04 AM on 6/28/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

76 Terms

1
New cards

Please check out my other flash card decks for help with your exams in Purdue Globals NU553 and prepare for Board Certification.

Ok!

2
New cards

Mild substance use disorder criteria count?

2 to 3

3
New cards

Moderate substance use disorder criteria count?

4 to 5

4
New cards

Severe substance use disorder criteria count?

6 or more

5
New cards

Reward pathway projection?

Ventral tegmental area to nucleus accumbens

6
New cards

Primary neurotransmitter reward pathway?

Dopamine

7
New cards

Inhibitory neurotransmitter on reward pathway?

Gamma aminobutyric acid

8
New cards

Cocaine mechanism?

Blocks monoamine reuptake

9
New cards

Amphetamine mechanism?

Blocks reuptake and increases release

10
New cards

SBIRT components?

Screening brief intervention referral

11
New cards

Opioid misuse screening tool?

Current Opioid Misuse Measure

12
New cards

Drug abuse screening tool?

DAST 10

13
New cards

Alcohol withdrawal onset?

6 to 12 hours

14
New cards

Alcohol withdrawal first line treatment?

Benzodiazepines

15
New cards

Delirium tremens timing?

48 to 72 hours

16
New cards

Delirium tremens symptoms?

Confusion hallucinations autonomic instability

17
New cards

AUD with liver disease best medication?

Acamprosate

18
New cards

Acamprosate contraindication?

Severe renal impairment

19
New cards

Acamprosate dose normal renal function?

666 milligrams three times daily

20
New cards

Acamprosate most common side effect?

Diarrhea

21
New cards

Disulfiram mechanism?

Blocks aldehyde dehydrogenase

22
New cards

Disulfiram counseling?

Avoid all alcohol sources

23
New cards

Naltrexone mechanism?

Opioid receptor antagonist

24
New cards

Naltrexone must avoid if?

Current opioid use

25
New cards

Naltrexone injection dose?

380 milligrams every 4 weeks

26
New cards

Alcohol vs opioid withdrawal risk?

Alcohol can be fatal opioid usually not

27
New cards

Pregnant OUD treatment?

Methadone

28
New cards

Opioid withdrawal scale?

Clinical Opioid Withdrawal Scale

29
New cards

Naloxone use?

Reverse opioid overdose

30
New cards

Naloxone repeat dosing?

Every 2 to 3 minutes if needed

31
New cards

Buprenorphine mechanism?

Partial opioid agonist

32
New cards

Buprenorphine start requirement?

Patient in withdrawal

33
New cards

Buprenorphine max dose?

24 milligrams daily

34
New cards

Buprenorphine metabolism?

CYP3A4

35
New cards

Lofexidine mechanism?

Alpha 2 agonist

36
New cards

Lofexidine adverse effect?

Hypotension bradycardia

37
New cards

Methadone starting dose?

10 to 30 milligrams

38
New cards

Methadone maintenance dose?

80 to 120 milligrams

39
New cards

Methadone major risk?

Respiratory depression QT prolongation

40
New cards

Preferred OUD outpatient treatment?

Buprenorphine

41
New cards

Why combine buprenorphine with naloxone?

Prevent injection misuse

42
New cards

Naltrexone challenge before start?

Naloxone challenge

43
New cards

Key deficiency in alcohol use disorder?

Thiamine

44
New cards

Give thiamine before what?

Glucose

45
New cards

Wernicke triad?

Confusion ataxia nystagmus

46
New cards

Heavy drinking male definition?

More than 4 drinks daily

47
New cards

Heavy drinking female definition?

More than 3 drinks daily

48
New cards

Standard drink alcohol grams?

14 grams

49
New cards

PCP mechanism?

NMDA receptor inhibition

50
New cards

Injectable naltrexone safety program?

Risk evaluation mitigation strategy

51
New cards

Oral naltrexone limitation?

Poor adherence

52
New cards

Lofexidine discontinuation?

Taper gradually

53
New cards

Lofexidine max dose?

2.88 milligrams daily

54
New cards

Alcohol screening quick tool?

CAGE

55
New cards

Monitor disulfiram labs?

Liver function tests

56
New cards

Lofexidine advantage?

Non opioid withdrawal treatment

57
New cards

If buprenorphine fails?

Switch to methadone

58
New cards

Opioid withdrawal onset short acting?

8 to 24 hours

59
New cards

Methadone withdrawal duration?

10 to 20 days

60
New cards

Neonatal abstinence syndrome cause?

Maternal drug use

61
New cards

Preferred benzo liver disease withdrawal?

Lorazepam or oxazepam

62
New cards

Methadone dispensing setting?

Opioid treatment program

63
New cards

Recovery definition?

Improved health and wellness

64
New cards

First line AUD maintenance?

Naltrexone or acamprosate

65
New cards

Key naltrexone safety point?

Must be opioid free

66
New cards

Methadone vs buprenorphine?

Full agonist vs partial agonist

67
New cards

Buprenorphine advantage?

Ceiling respiratory effect

68
New cards

Naloxone role?

Reverse overdose

69
New cards

SBIRT purpose?

Early identification intervention

70
New cards

DT timing?

48 to 72 hours

71
New cards

If liver disease benzodiazepine?

Lorazepam or oxazepam

72
New cards

If pregnancy OUD?

Methadone

73
New cards

Thiamine role?

Prevent Wernicke encephalopathy

74
New cards

If poor adherence AUD?

Use injectable naltrexone

75
New cards

Opioid vs alcohol withdrawal?

Alcohol life threatening

76
New cards

If still using opioids avoid?

Naltrexone